Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $5,231 - $8,326
41 Added 1.79%
2,332 $472,000
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $77,581 - $91,991
661 Added 40.55%
2,291 $294,000
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $3,517 - $4,682
26 Added 1.62%
1,630 $223,000
Q2 2022

Aug 12, 2022

SELL
$108.81 - $179.33 $105,654 - $174,129
-971 Reduced 37.71%
1,604 $284,000
Q4 2021

Feb 14, 2022

SELL
$142.57 - $190.86 $49,899 - $66,801
-350 Reduced 11.97%
2,575 $398,000
Q3 2021

Nov 15, 2021

SELL
$142.45 - $169.82 $38,461 - $45,851
-270 Reduced 8.45%
2,925 $497,000
Q2 2021

Aug 10, 2021

SELL
$135.08 - $161.1 $4,592 - $5,477
-34 Reduced 1.05%
3,195 $504,000
Q1 2021

May 17, 2021

BUY
$137.51 - $190.8 $444,019 - $616,093
3,229 New
3,229 $448,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.